🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Longer remissions. Better quality of life. ❤️ We’re proud to help bring breakthrough therapies to life and to bring that progress to even more chronic lymphocytic leukemia (CLL) patients. Here’s what’s on the horizon 👉 bit.ly/4kivVbQ

New data from TAP partner Faron Pharmaceuticals presented at #ASCO25 highlights safety, tolerability and preliminary efficacy of a potential treatment for patients with high-risk myelodysplastic syndrome. Learn more 👉 bit.ly/4kjzi2h

In an #ASCO25 session, LLS TAP partner Affimed shares data on a new treatment approach for relapsed or refractory classical Hodgkin lymphoma. Learn more about the research on this combination therapy 👉 bit.ly/4khG4Wa

LLS TAP partner @KuraOncology presents data from the pivotal KOMET-001 study at #ASCO25 and discusses the potential of an investigational menin inhibitor for patients with certain types of #AML. Learn more 👉 msg.lls.org/3Hl6ZSC

Research from LLS TAP partner ImCheck Therapeutics presented at #ASCO25 provides an update from their phase 1/2 study in patients with newly diagnosed acute myeloid leukemia. Learn more about the study 👉 msg.lls.org/4ky9lvS

As #ASCO25 ends, we're feeling proud of our role in funding research and thinking about how it will help us reach our bold goal of enabling patients with blood cancer to gain more than one million years of life. Learn more👉 msg.lls.org/43GTO5R

2025 Merkin Prize = earned. ❤️ Honoring the science behind CAR T-cell therapy—and the people who made it possible: 🎉 Pictured: Dr. Carl June, Penn 🎉 Pictured: Dr. Michel Sadelain, Columbia University 🎉 Dr. Isabelle Riviere, Memorial Sloan Kettering Cancer Center 🎉 Dr. Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉, Penn We backed early

No one should face blood cancer alone. 🫂 ​ We’re here with support, information, and a community that truly understands 👉 bit.ly/4kR6Ft0